The United States’ Centers for Disease Control and Prevention (CDC for its acronym) panel of experts gave the go-ahead for the Pfizer vaccine booster dose for people over 65 years of age after eating and Drug Administration (FDA) this Thursday this third vaccine approved the day before.
The CDC’s Advisory Committee on Immunization Practices (ACIP) has also recommended the third dose for residents of long-term care facilities or those aged 18 and over with underlying medical conditions who could have the disease.
However, the panel has voted against the recommendation of the third dose for people between the ages of 18 and 64 who are “at risk” for COVID-19 due to their occupational or lifestyle exposure.
In this way, they differ from those approved by the FDA, which supported the third vaccine for this group, which included teachers, daycare staff, supermarket employees, and those who work in homeless shelters or prisons.
After the decision of the panel of experts, the director of the CDC, Rochelle Walensky, will make the final decision on the third dose and the groups that can receive it – this booster dose will be given at least six months after the completion of the primary schedule, i.e. the first doses, as in an FDA opinion stated on Wednesday evening.
The CDC Expert Panel’s recommendation comes one day after the FDA approves the booster dose, which stipulated that if approved, it should be given at least six months after the completion of primary therapy, i.e. the first doses.